Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy?
Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions. This over-thecounter product is considered safe, but...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2016-08-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/8250/19679_CE[Ra1]_F(P)_PF1(ASAK)_PFA(AK)_PF2(PAG).pdf |
| _version_ | 1818582325897723904 |
|---|---|
| author | Habibullah Aktas Sevil Alan Elif Betül Türkoglu Özge Sevik |
| author_facet | Habibullah Aktas Sevil Alan Elif Betül Türkoglu Özge Sevik |
| author_sort | Habibullah Aktas |
| collection | DOAJ |
| description | Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and
US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions. This over-thecounter product is considered safe, but should be used with caution. Furthermore, minoxidil is an orally active vasodilator for treatment
of severe hypertension. Typical side effects of minoxidil are faster heart rate, augmented heart function and stroke volume (which can be
associated with reduced vascular resistance upon baroflex stimulus), retained sodium and water and abnormal hair growth. The most
common adverse reactions of the topical formulation are limited to irritant and allergic contact dermatitis on the scalp. Herein, we report
a non-arteritic anterior ischemic optic neuropathy caused by topical 5% minoxidil treatment that was resolved after discontinuation of
minoxidil. |
| first_indexed | 2024-12-16T07:47:36Z |
| format | Article |
| id | doaj.art-794fb4cc553a45c8a12f4e420ae3451f |
| institution | Directory Open Access Journal |
| issn | 2249-782X 0973-709X |
| language | English |
| last_indexed | 2024-12-16T07:47:36Z |
| publishDate | 2016-08-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj.art-794fb4cc553a45c8a12f4e420ae3451f2022-12-21T22:38:56ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-08-01108WD01WD0210.7860/JCDR/2016/19679.8250Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy?Habibullah Aktas0Sevil Alan1Elif Betül Türkoglu2Özge Sevik3Assistant Professor, Department of Dermatology and Venereology, Karabük Education and Researh Hospital, Karabük.Consultant Dermatologist, Department of Dermatology and Venereology, Akdeniz University School of Medicine, Antalya. Assistant Professor, Department of Ophtalmology, Akdeniz University School of Medicine, Antalya. Consultant Ophtalmologist, Department of Ophtalmology, Karabük Education and Researh Hospital, Karabük.Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions. This over-thecounter product is considered safe, but should be used with caution. Furthermore, minoxidil is an orally active vasodilator for treatment of severe hypertension. Typical side effects of minoxidil are faster heart rate, augmented heart function and stroke volume (which can be associated with reduced vascular resistance upon baroflex stimulus), retained sodium and water and abnormal hair growth. The most common adverse reactions of the topical formulation are limited to irritant and allergic contact dermatitis on the scalp. Herein, we report a non-arteritic anterior ischemic optic neuropathy caused by topical 5% minoxidil treatment that was resolved after discontinuation of minoxidil.https://jcdr.net/articles/PDF/8250/19679_CE[Ra1]_F(P)_PF1(ASAK)_PFA(AK)_PF2(PAG).pdfandrogeneticalopeciaeyeoptic nervenaion |
| spellingShingle | Habibullah Aktas Sevil Alan Elif Betül Türkoglu Özge Sevik Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? Journal of Clinical and Diagnostic Research androgeneticalopecia eye optic nerve naion |
| title | Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? |
| title_full | Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? |
| title_fullStr | Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? |
| title_full_unstemmed | Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? |
| title_short | Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? |
| title_sort | could topical minoxidil cause non arteritic anterior ischemic optic neuropathy |
| topic | androgeneticalopecia eye optic nerve naion |
| url | https://jcdr.net/articles/PDF/8250/19679_CE[Ra1]_F(P)_PF1(ASAK)_PFA(AK)_PF2(PAG).pdf |
| work_keys_str_mv | AT habibullahaktas couldtopicalminoxidilcausenonarteriticanteriorischemicopticneuropathy AT sevilalan couldtopicalminoxidilcausenonarteriticanteriorischemicopticneuropathy AT elifbetulturkoglu couldtopicalminoxidilcausenonarteriticanteriorischemicopticneuropathy AT ozgesevik couldtopicalminoxidilcausenonarteriticanteriorischemicopticneuropathy |